Zortrax S.A. (WSE:ZRX)
Poland · Delayed Price · Currency is PLN 0.0495
+0.0020 (4.21%)
At close: Jul 24, 2026
Zortrax Revenue
Zortrax had revenue of 1.25M PLN in the twelve months ending March 31, 2026, down -75.71% year-over-year. In the year 2025, Zortrax had annual revenue of 2.40M, down -62.81%.
Revenue (ttm)
1.25M
Revenue Growth
-75.71%
P/S Ratio
0.12
Revenue / Employee
109.20K
Employees
1
Market Cap
1.09M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.40M | -4.05M | -62.81% |
| Dec 31, 2024 | 6.45M | -8.59M | -57.11% |
| Dec 31, 2023 | 15.04M | -25.12M | -62.55% |
| Dec 31, 2022 | 40.15M | 20.07M | 99.93% |
| Dec 31, 2021 | 20.08M | 19.08M | 1,910.90% |
| Dec 31, 2020 | 998.73K | -1.41M | -58.53% |
| Dec 31, 2019 | 2.41M | -684.24K | -22.12% |
| Dec 31, 2018 | 3.09M | -176.79K | -5.41% |
| Dec 31, 2017 | 3.27M | 418.42K | 14.68% |
| Dec 31, 2016 | 2.85M | 648.30K | 29.43% |
| Dec 31, 2015 | 2.20M | 1.02M | 85.49% |
| Dec 31, 2014 | 1.19M | 978.04K | 466.85% |
| Dec 31, 2013 | 209.50K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Synektik Spólka Akcyjna | 794.94M |
| Medicalgorithmics | 34.45M |
| InventionMed | 3.74M |
| Nestmedic | 1.15M |
| Adiuvo Investments | 431.00K |
| Genomtec | 30.00K |
| Medinice | 19.00K |
| Milton Essex Spólka Akcyjna | 1.46K |